{"id":2601,"date":"2020-08-22T21:38:09","date_gmt":"2020-08-22T21:38:09","guid":{"rendered":"https:\/\/www.cubasupport.ie\/latest\/?p=2601"},"modified":"2020-08-22T21:38:12","modified_gmt":"2020-08-22T21:38:12","slug":"cuba-moves-closer-to-our-own-covid-19-vaccine","status":"publish","type":"post","link":"https:\/\/www.cubasupport.ie\/latest\/cuba-moves-closer-to-our-own-covid-19-vaccine\/","title":{"rendered":"Cuba moves closer to our own COVID-19 vaccine"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Authorization granted to the Finlay Vaccine Institute to begin clinical trials of new vaccine in collaboration with Ministry of Public Health institutions<\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" width=\"700\" height=\"466\" src=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?resize=700%2C466&#038;ssl=1\" alt=\"\" class=\"wp-image-2602\" srcset=\"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?w=700&amp;ssl=1 700w, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?resize=300%2C200&amp;ssl=1 300w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><figcaption>This past July 28, Cuba\u2019s candidate vaccine was tested for the first time on human volunteers, precisely three researchers participating in its development. An initial evaluation revealed a strong immune response in all three. Photo: BioCubaFarma<\/figcaption><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">The central state enterprise management group BioCubaFarma reports having received permission to begin clinical trials of a Cuban candidate vaccine to prevent COVID-19, capable of producing a strong immune reaction to a SARS-COV-2 infection.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Identified as FINLAY-FR-1, the vaccine project led by the Finlay Vaccine Institute, the Center for Molecular Immunology &#8211; both affiliated with BioCubaFarma \u2013 with the collaboration of the University of Havana\u2019s Chemical and Biomolecular Synthesis Laboratory, has satisfactorily concluded the drug\u2019s development stage and pre-clinical studies in animals, producing the scientific findings required to support authorization, by Cuba\u2019s Center for State Control of Medications, Medical Equipment and Devices (Cecmed), to conduct clinical trials.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The announcement explained that this license allows for joint work with different institutions affiliated with the Ministry of Public Health to begin at this time, initiating \u201cthe clinical trial phase I-II, known as Sovereign, which will be followed by other clinical studies, before the vaccine is considered ready for use.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">BioCubaFarma also reported that an industrial production strategy is being developed to build capacity with the goal of \u201chaving available the millions of doses needed to protect our population,\u201d once the studies are concluded.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Also of special interest is the fact reported that Cuba\u2019s candidate vaccine is the 30th &#8211; the first in Latin America and the Caribbean &#8211; to receive authorization for clinical trials, among the more than 200 under development around the world.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The Finlay Vaccine Institute, which submitted the license application, has more than 30 years of experience in developing vaccines, the announcement notes, stating, \u201cThe fact that the Institute has available platforms developed for other epidemics, specifically that developed for the meningitis epidemic in the 1980s, allowed these important results to be obtained.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">BioCubaFarma, the leading enterprise group in Cuba\u2019s biotechnology and pharmaceutical industry, described the progress made in the urgent effort to develop a vaccine here as a tribute to Comandante en Jefe Fidel Castro Ruz, visionary founder and promoter of the sector, while taking healthy pride in the results achieved, called on the entire population to maintain rigorous implementation of preventative measures to contain the epidemic, as the country draws closer to producing our own vaccine.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201cThese have been weeks of intense work and self-sacrifice, very tense days, during which we have counted on the intelligence and commitment of our scientific community that has as its priority protecting health and saving lives, and assures the people that there will be no rest until every Cuban is protected from this terrible disease with a vaccine, but that, at this time, it is important to continue adhering to the hygienic-sanitary precautions established by the Ministry of Public Health to confront COVID-19.\u201d<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Source: <a href=\"http:\/\/en.granma.cu\/cuba\/2020-08-20\/cuba-moves-closer-to-our-own-covid-19-vaccine\" data-type=\"URL\" data-id=\"http:\/\/en.granma.cu\/cuba\/2020-08-20\/cuba-moves-closer-to-our-own-covid-19-vaccine\" target=\"_blank\" rel=\"noreferrer noopener\">Granma<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Authorization granted to the Finlay Vaccine Institute to begin clinical trials of new vaccine in collaboration with Ministry of Public Health institutions The central state<a class=\"moretag\" href=\"https:\/\/www.cubasupport.ie\/latest\/cuba-moves-closer-to-our-own-covid-19-vaccine\/\"> [&#8230;]<\/a><\/p>\n","protected":false},"author":101011,"featured_media":2602,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[8],"tags":[],"class_list":["post-2601","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-cuba"],"jetpack_publicize_connections":[],"jetpack-related-posts":[{"id":2972,"url":"https:\/\/www.cubasupport.ie\/latest\/sovereign-2-closer-to-starting-clinical-trials\/","url_meta":{"origin":2601,"position":0},"title":"Sovereign 2, closer to starting clinical trials","author":"Editorial Team","date":"October 20, 2020","format":false,"excerpt":"Doctor of Science Vicente V\u00e9rez Bencomo, general director of the Finlay Vaccine Institute, belonging to the BioCubaFarma Business Group, affirmed in an interview with Granma that the so-called Sovereign 2 is an innovative vaccine, as it has no precedent among all those that are developed to face COVID-19 in the\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0180751.jpg?fit=700%2C584&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":2987,"url":"https:\/\/www.cubasupport.ie\/latest\/soverana-2-closer-to-starting-clinical-trials\/","url_meta":{"origin":2601,"position":1},"title":"Soverana 2, closer to starting clinical trials","author":"Editorial Team","date":"October 22, 2020","format":false,"excerpt":"Doctor of Sciences Vicente V\u00e9rez Bencomo, general director of the Finlay Vaccine Institute, belonging to the BioCubaFarma Business Group, affirmed in an interview with Granma that the so-called Sovereign 2 is an innovative vaccine, as it has no precedent among all those that are developed to face COVID-19 in the\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/covid-cuba-vacuna-soberana.jpg?fit=748%2C498&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3484,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-and-iran-alliance-on-covid-19-vaccine\/","url_meta":{"origin":2601,"position":2},"title":"Cuba and Iran alliance on COVID-19 vaccine","author":"Editorial Team","date":"January 12, 2021","format":false,"excerpt":"Cuba and\u00a0Iran\u00a0signed a bilateral agreement last Friday that establishes an alliance in the work for the development of a COVID-19 vaccine. The agreement was signed by the Finlay Vaccine Institute, belonging to the Cuban state group BioCubaFarma, and the Iranian Pasteur Institute \u201cto complement clinical evidence of the Soberana 02\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=700%2C400 2x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Iran-Cuba-Agreemtn-Covid-19-vaccine-cooperation.jpg?fit=1080%2C602&ssl=1&resize=1050%2C600 3x"},"classes":[]},{"id":3083,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-develops-another-vaccine-against-the-coronavirus-and-it-is-not-injectable\/","url_meta":{"origin":2601,"position":3},"title":"Cuba develops another vaccine against the coronavirus and it is not injectable","author":"Editorial Team","date":"November 3, 2020","format":false,"excerpt":"Center for Genetic Engineering and Biotechnology (CIGB) of Cuba. Photo: Dunia \u00c1lvarez Palacios \/ Granma. The Cuban scientific community is working today on a third vaccine candidate against COVID-19,\u00a0the first that is not an injectable and would be applied nasal. Developed by the Center for Genetic Engineering and Biotechnology (CIGB),\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Centro-de-Ingenieria-Genetica-y-Biotecnologia-CIGB-de-Cuba-580x446-1.jpg?fit=580%2C446&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Centro-de-Ingenieria-Genetica-y-Biotecnologia-CIGB-de-Cuba-580x446-1.jpg?fit=580%2C446&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/Centro-de-Ingenieria-Genetica-y-Biotecnologia-CIGB-de-Cuba-580x446-1.jpg?fit=580%2C446&ssl=1&resize=525%2C300 1.5x"},"classes":[]},{"id":4712,"url":"https:\/\/www.cubasupport.ie\/latest\/cubas-abdala-vaccine-proved-92-28-effective-in-last-stage-clinical-trials\/","url_meta":{"origin":2601,"position":4},"title":"Cuba&#8217;s Abdala vaccine proved 92.28% effective in last-stage clinical trials.","author":"Editorial Team","date":"June 22, 2021","format":false,"excerpt":"Cuba said on Monday its three-shot Abdala vaccine against the coronavirus had proved 92.28% effective in last-stage clinical trials. The announcement came just days after the government said another homegrown vaccine, Soberana 2, had proved 62% effective with just two of its three doses. \"Hit by the pandemic, our scientists\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/IMG_8871.jpg?fit=960%2C960&ssl=1&resize=700%2C400 2x"},"classes":[]},{"id":3578,"url":"https:\/\/www.cubasupport.ie\/latest\/cuba-will-vaccinate-its-entire-population-against-covid-19-in-2021\/","url_meta":{"origin":2601,"position":5},"title":"Cuba will vaccinate its entire population against COVID-19 in 2021","author":"Editorial Team","date":"January 27, 2021","format":false,"excerpt":"The BioCubaFarma enterprise group is adjusting capacity to make possible the administration of Soberana 02 to more than 150,000 persons, while a new clinical trial with children has been launched, as more steps are taken along the path to vaccinating the entire population. Photo: BioCubaFarma Dr. Eduardo Mart\u00ednez, president of\u2026","rel":"","context":"In &quot;Covid-19&quot;","block_context":{"text":"Covid-19","link":"https:\/\/www.cubasupport.ie\/latest\/category\/cuba\/covid-19\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=350%2C200","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=350%2C200 1x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=525%2C300 1.5x, https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/f0027859.jpg?fit=700%2C406&ssl=1&resize=700%2C400 2x"},"classes":[]}],"jetpack_likes_enabled":true,"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p3xdTY-FX","jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.cubasupport.ie\/latest\/wp-content\/uploads\/vacine-cuba.jpg?fit=700%2C466&ssl=1","_links":{"self":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/2601","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/users\/101011"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/comments?post=2601"}],"version-history":[{"count":0,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/posts\/2601\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media\/2602"}],"wp:attachment":[{"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/media?parent=2601"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/categories?post=2601"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cubasupport.ie\/latest\/wp-json\/wp\/v2\/tags?post=2601"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}